The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria

Journal:

Science Translational Medicine

Published:

2026-06-10

DOI:

10.1126/scitranslmed.aec1863

Affiliations:

10

Authors:

29

Go to article

Institutions	Authors	Share
University of the Sunshine Coast (USC), Australia	6.333333	0.22
QIMR Berghofer Medical Research Institute, Australia	5.833333	0.20
Medicines for Malaria Venture (MMV), Switzerland	5.000000	0.17
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	4.000000	0.14
GSK, United Kingdom (UK)	3.000000	0.10
GlaxoSmithKline Spain, Spain	2.000000	0.07
University of New South Wales (UNSW Sydney), Australia	1.000000	0.03
ICON - Germany, Germany	1.000000	0.03
George Institute - Australia (TGI Australia), Australia	0.500000	0.02
Royal Brisbane and Women's Hospital (RBWH), Australia	0.333333	0.01